Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Alunno

Showing results (61-70 of 228) with videos related to

Pageof 23
Sort By:
Expert Review of Clinical Immunology|May 19, 2010
Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseasesElena Bartoloni Bocci, Filippo Luccioli, Claudio Angrisani, et al.
Clinical and Experimental Rheumatology|July 27, 2023
Pathogenesis of rheumatoid arthritis: one year in review 2023Francesco Maria Mariani, Irene Martelli, Francesca Pistone, et al.
Nutrients|April 13, 2023
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren's Syndrome: Is Uric Acid the Missing Link?Alessia Alunno, Francesco Carubbi, Francesco Maria Mariani, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The management of cardiovascular risk in psoriatic disease: A bridge over troubled waterAlessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio, et al.
Rheumatology (Oxford, England)|September 19, 2023
Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient surveyGiulia Bandini, Alessia Alunno, Barbara Ruaro, et al.
Expert Review of Clinical Immunology|January 10, 2020
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasisMaria Esposito, Francesco Carubbi, Alessandro Giunta, et al.
Seminars in Arthritis and Rheumatism|November 10, 2022
Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud's phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorderMichael Hughes, Hafiz M Umair, Robert D Sandler, et al.
Rheumatology (Oxford, England)|July 25, 2023
Divergence of patient-reported xerostomia and oral health in primary Sjögren's syndrome and the possible role of hydroxychloroquineAlessia Alunno, Francesco Carubbi, Francesco Maria Mariani, et al.
Seminars in Arthritis and Rheumatism|October 16, 2021
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping reviewHafiz M Umair, Robert D Sandler, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|March 29, 2014
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humansAlessia Alunno, Francesco Carubbi, Sara Caterbi, et al.
Pageof 23

Showing results (61-70 of 228) with videos related to

Sort By:
Pageof 23
Expert Review of Clinical Immunology|May 19, 2010
Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseasesElena Bartoloni Bocci, Filippo Luccioli, Claudio Angrisani, et al.
Clinical and Experimental Rheumatology|July 27, 2023
Pathogenesis of rheumatoid arthritis: one year in review 2023Francesco Maria Mariani, Irene Martelli, Francesca Pistone, et al.
Nutrients|April 13, 2023
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren's Syndrome: Is Uric Acid the Missing Link?Alessia Alunno, Francesco Carubbi, Francesco Maria Mariani, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The management of cardiovascular risk in psoriatic disease: A bridge over troubled waterAlessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio, et al.
Rheumatology (Oxford, England)|September 19, 2023
Significant gastrointestinal unmet needs in patients with Systemic Sclerosis: insights from a large international patient surveyGiulia Bandini, Alessia Alunno, Barbara Ruaro, et al.
Expert Review of Clinical Immunology|January 10, 2020
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasisMaria Esposito, Francesco Carubbi, Alessandro Giunta, et al.
Seminars in Arthritis and Rheumatism|November 10, 2022
Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud's phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorderMichael Hughes, Hafiz M Umair, Robert D Sandler, et al.
Rheumatology (Oxford, England)|July 25, 2023
Divergence of patient-reported xerostomia and oral health in primary Sjögren's syndrome and the possible role of hydroxychloroquineAlessia Alunno, Francesco Carubbi, Francesco Maria Mariani, et al.
Seminars in Arthritis and Rheumatism|October 16, 2021
Association between central nervous system stimulants used to treat attention deficit hyperactivity disorder (ADHD) and Raynaud's phenomenon: A scoping reviewHafiz M Umair, Robert D Sandler, Alessia Alunno, et al.
Annals of the Rheumatic Diseases|March 29, 2014
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humansAlessia Alunno, Francesco Carubbi, Sara Caterbi, et al.
Pageof 23